Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 15,000 shares at $195.66 ($2.9M) on 2014-11-11, disclosed to the SEC on 2014-11-13.
Seasonal sale ($2.9M) by Director — this insider has traded ALXN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-05-15 | $2.0M | — | Filing → |